ISMP Medication Safety Alert!®

Community/Ambulatory

A valuable resource to reduce medication error risk in outpatient settings

The ISMP Medication Safety Alert!®Community/Ambulatory Care is a 4-5 page digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, outpatient clinics, physician offices, and state institutions.

Who reads this newsletter?

  • Community/ambulatory care pharmacists
  • Pharmacy managers and executives
  • Pharmacy technicians and other pharmacy staff
  • Physicians and nurses in ambulatory practice
  • Anyone concerned with medication safety

Subscription Information

  • Twelve (12) issues per year
  • One-year subscription rate: $64.00
  • Distributed via email on a monthly basis
  • Special pricing for group purchases; contact ISMP 
  • One-year subscriptions start from the date of purchase. You will be granted access to issues released after date of purchase for one year. This does not include access to back issues.

Browse Issues

This month's main topic: QuarterWatchTM (includes new data from Quarter 4, 2018 and Quarter 1, 2019): Focus on Four New Drugs: Xofluza, Aimovig, Ajovy, and Emgality
This month's main topic: ISMP National Vaccine Errors Reporting Program 2017 Analysis: Vaccine Errors Continue with Little Change
This month's main topic: QuarterWatch™ (Quarter 3 2017): Emerging Risks with Inhaled Medications Using the Ellipta Device, the Controversy with Antidepressants, and Loperamide Abuse